Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases
US9051327B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2014 |
| Grant date | Jun 9, 2015 |
| Priority date | — |
| Expiry date | Jun 18, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts,wherein B, R1, R2, R4, and m are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as wee-1 and methods of treating diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.